Omnicom Health Explores The New Age of Cancer

Cancer has long been a disease associated with older adults, but the landscape is shifting. Incidence rates among younger adults aged 18-49 have increased dramatically in recent decades, presenting unique challenges for patients, providers and the broader healthcare system.

Omnicom Health's "The New Age of Cancer" initiative explores this urgent issue, bringing together leading voices to reimagine how we detect, treat and support younger patients.

Through a series of roundtables, articles and reports, this initiative provides a deeper look into the realities facing this emerging patient population and offers a blueprint for evolving the oncology landscape to better support younger adults with cancer across diagnosis, treatment and survivorship.

The New Age of Cancer Culminating Report

Drawing on oncologist insights, advocacy perspectives, Omnicom Health experts and Omni for Health's LivingPersonas data, this culminating report identifies systemic gaps and outlines tangible ways in which the oncology ecosystem can evolve to better meet the needs of this "invisible generation" of cancer patients-younger adults building careers, families and financial stability-as well as the financial, professional and reproductive challenges they face.

Read The New Age of Cancer Culminating Report

Young Adults: The Invisible Generation of Cancer Patients

Young adults diagnosed with cancer have little choice but to navigate a treatment ecosystem built for children and seniors. Here's an Rx for reimagining their journey.

Read the full story in FiercePharma

AI, Wearables and Connected Data: Rewiring Cancer Care for a Younger Generation

Experts from across our network and Northwell Health weigh in on how younger cancer patients are benefiting from new tools reshaping the detection and engagement landscapes.

Read the full story in FiercePharma

The Oncologists' Perspective: A Roundtable Discussion

Our roundtable discussion gathered experts including Memorial Sloan Kettering Cancer Center's Dr. Michael Foote, Yale School of Medicine's Dr. Adriana Kahn, Northwell Health's Dr. Daniel King, Dana-Farber Institute's Dr. Guilherme Nader Marta, and our Chief Medical Officer Sommer Bazuro, PhD, to examine the realities facing this emerging patient population.

Moderated by Erin Billups, National Health Reporter at Spectrum News, the discussion explored:

• Hypotheses on why cancer is appearing earlier
• How younger patients navigate diagnosis
• The impact of life stage on treatment decisions
• The emotional and professional toll on oncologists, PCPs and more

Watch the roundtable